ERNA - CIK 0000748592
The table below shows Eterna Therapeutics Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | $4.32M | $1.92M | $4.26M | $2.59M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $10.00M |
| $3.38M |
| $4.79M |
| $2.21M |
| $4.73M |
| $3.58M |
| Property, plant & equipment | $88.00K | $92.00K | $50.00K | $67.00K | $105.00K | $654.00K |
| Goodwill | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M |
| Total assets | $10.54M | $6.17M | $7.58M | $5.06M | $7.72M | $46.49M |
| Accounts payable | $1.30M | $958.00K | $1.32M | $1.27M | $2.19M | $2.19M |
| Total current liabilities | $3.46M | $2.14M | $2.65M | $10.44M | $9.95M | $9.60M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $3.68M | $2.60M | $3.14M | $11.01M | $53.11M | $55.01M |
| Retained earnings | -$251.14M | -$244.13M | -$242.88M | -$239.74M | -$225.77M | -$199.16M |
| Total equity | $6.86M | $3.57M | $4.44M | -$5.95M | -$45.39M | -$8.53M |